Browse studies

Find your next paid study

60 recruiting studies matching your filters

Pioneering Research to Optimize Pre-exposure Prophylaxis (PrEP) Expansion With Lenacapavir (LEN)

The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) …

HIV Infections

Estimated

~$10 – $1,125

Gilead SciencesNCT07473778

Phase 1

Geroprotective Precision Medicine Strategies in PWH That Use Alcohol

People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, cr…

HIV InfectionsAlcohol DrinkingAging+1 more

Estimated

~$10 – $6,250

Louisiana State University Health Sciences Center in New OrleansNCT07462767

Phase 3

A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART

This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and a…

HIV Infections

Estimated

~$10 – $7,500

ViiV HealthcareNCT07650916

Observational

Discrete Choice Experiments for HIV Prevention in Atlanta Adolescents- Atlanta

This study applies Social Cognitive Theory to develop behavioral interventions promoting PrEP adherence. It seeks to adapt and test the enhanced HMP app for fe…

HIV Infections

Estimated

~$10 – $6,250

Emory UniversityNCT07535346

Observational

Evaluating the Camino Intervention to Reduce HIV Risk and Poor Care Outcomes Among Latin Americans

The Camino Study evaluates a status-neutral, multi-level pilot intervention designed to improve HIV prevention and care engagement among Latin Americans with u…

HIV Infections

Estimated

~$10 – $6,250

American UniversityNCT07834853

Observational

The TAIL-PrEP Study: Acceptability and Feasibility of a Tailored Adherence Intervention for Safe Discontinuation of Long-acting PrEP

The goal of the TAIL-PrEP study is to understand how to support the safe discontinuation of injectable long-acting cabotegravir (cab-LA) and lenacapavir (LEN) …

HIV Infections

Estimated

~$10 – $6,250

Columbia UniversityNCT06868641

Phase 1

A Phase 1 Open-label, Non-randomized, Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged …

HIV Infections

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT06665646

Observational

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severit…

Substance UseHIV Infections

Estimated

~$10 – $6,250

Hunter College of City University of New YorkNCT06307977

Observational

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

This is a multi-phased study, funded through a National Institute on Drug Abuse (NIDA) K24 grant that aims to ultimately refine a virtual reality tool through …

Substance Use DisordersHIV Infections

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT05816083

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical …

HIV Infections

Estimated

~$10 – $675

University of California, San FranciscoNCT00187512

Phase 2

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteri…

MicrotiaDysbiosisAlcohol Drinking+2 more

Estimated

~$10 – $6,250

Vanderbilt University Medical CenterNCT05288790

Phase 4

Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

The investigators plan to conduct an R61/33 hybrid type 2 implementation-effectiveness trial that includes 1) a one-year exploratory R61 phase that will enable…

HIV InfectionsOpioid Use DisorderIncarceration; Lens

Estimated

~$10 – $6,250

Duke UniversityNCT06854029